GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Cash-to-Debt

Cantourage Group SE (XTER:HIGH) Cash-to-Debt : No Debt (1) (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Cantourage Group SE's cash to debt ratio for the quarter that ended in Jun. 2023 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Cantourage Group SE could pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Cantourage Group SE's Cash-to-Debt or its related term are showing as below:

XTER:HIGH' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt   Med: No Debt   Max: No Debt
Current: No Debt

During the past 4 years, Cantourage Group SE's highest Cash to Debt Ratio was No Debt. The lowest was No Debt. And the median was No Debt.

XTER:HIGH's Cash-to-Debt is ranked better than
99.81% of 1053 companies
in the Drug Manufacturers industry
Industry Median: 0.93 vs XTER:HIGH: No Debt

Cantourage Group SE Cash-to-Debt Historical Data

The historical data trend for Cantourage Group SE's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cantourage Group SE Cash-to-Debt Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Cash-to-Debt
No Debt No Debt No Debt No Debt

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
Cash-to-Debt Get a 7-Day Free Trial No Debt No Debt N/A No Debt No Debt

Competitive Comparison of Cantourage Group SE's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's Cash-to-Debt falls into.



Cantourage Group SE Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Cantourage Group SE's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cantourage Group SE had no debt (1).

Cantourage Group SE's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cantourage Group SE had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE  (XTER:HIGH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Cantourage Group SE Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines